$ALGN
ALIGN TECHNOLOGY INC Stock $algn

$algn Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-Q Financial Statement

#000109714913000016 Filed on May 03, 2013

Income Statement

Concept	2013 Q1	2012 Q1
Revenue	$153.6M	$135.1M
YoY Change	13.7%	28.82%
Cost Of Revenue	$40.73M	$34.32M
YoY Change	18.68%	51.65%
Gross Profit	$112.8M	$100.8M
YoY Change	12.0%	22.54%
Gross Profit Margin	73.48%	74.59%
Selling, General & Admin	$72.63M	$62.23M
YoY Change	16.71%	20.1%
% of Gross Profit	64.36%	61.76%
Research & Development	$11.28M	$10.53M
YoY Change	7.18%	12.1%
% of Gross Profit	10.0%	10.45%
Depreciation & Amortization	$4.944M	$3.900M
YoY Change	26.77%	5.41%
% of Gross Profit	4.38%	3.87%
Operating Expenses	$150.9M	$72.75M
YoY Change	107.44%	18.87%
Operating Profit	-$38.08M	$28.01M
YoY Change	-235.95%	33.22%
Interest Expense	$200.0K	$200.0K
YoY Change	0.0%	0.0%
% of Operating Profit		0.71%
Other Income/Expense, Net	-$988.0K	-$812.0K
YoY Change	21.67%	-1012.36%
Pretax Income	-$39.06M	$27.19M
YoY Change	-243.65%	28.81%
Income Tax	$2.920M	$6.210M
% Of Pretax Income		22.84%
Net Earnings	-$41.98M	$20.98M
YoY Change	-300.07%	32.47%
Net Earnings / Revenue	-27.34%	15.53%
Basic Earnings Per Share	-$0.52	$0.26
Diluted Earnings Per Share	-$0.52	$0.26
COMMON SHARES
Basic Shares Outstanding	81.25M shares	79.24M shares
Diluted Shares Outstanding	81.25M shares	81.86M shares

Balance Sheet

Concept	2013 Q1	2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$366.7M	$240.4M
YoY Change	52.56%	-24.15%
Cash & Equivalents	$328.7M	$224.4M
Short-Term Investments	$37.98M	$16.02M
Other Short-Term Assets	$36.50M	$37.20M
YoY Change	-1.88%	53.72%
Inventory	$15.44M	$13.43M
Prepaid Expenses
Receivables	$108.7M	$94.44M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$527.3M	$385.5M
YoY Change	36.79%	-7.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$72.67M	$62.91M
YoY Change	15.51%	104.93%
Goodwill	$58.54M	$135.8M
YoY Change	-56.9%
Intangibles	$25.43M	$48.88M
YoY Change	-47.97%
Long-Term Investments	$10.70M	$16.80M
YoY Change	-36.31%	200.0%
Other Assets	$3.173M	$2.909M
YoY Change	9.08%	-92.85%
Total Long-Term Assets	$198.9M	$293.0M
YoY Change	-32.11%	261.04%
TOTAL ASSETS
Total Short-Term Assets	$527.3M	$385.5M
Total Long-Term Assets	$198.9M	$293.0M
Total Assets	$726.2M	$678.5M
YoY Change	7.04%	35.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.75M	$14.64M
YoY Change	34.89%	121.82%
Accrued Expenses	$64.64M	$66.54M
YoY Change	-2.86%	51.57%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$143.9M	$135.8M
YoY Change	5.91%	54.35%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$21.27M	$11.59M
YoY Change	83.6%	67.91%
Total Long-Term Liabilities	$21.27M	$11.59M
YoY Change	83.6%	67.91%
TOTAL LIABILITIES
Total Short-Term Liabilities	$143.9M	$135.8M
Total Long-Term Liabilities	$21.27M	$11.59M
Total Liabilities	$165.1M	$147.4M
YoY Change	12.02%	55.34%
SHAREHOLDERS EQUITY
Retained Earnings	-$133.4M	-$97.17M
YoY Change	37.26%
Common Stock	$8.000K	$8.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$561.1M	$531.1M
YoY Change
Total Liabilities & Shareholders Equity	$726.2M	$670.4M
YoY Change	8.32%	34.9%

Cashflow Statement

Concept	2013 Q1	2012 Q1
OPERATING ACTIVITIES
Net Income	-$41.98M	$20.98M
YoY Change	-300.07%	32.47%
Depreciation, Depletion And Amortization	$4.944M	$3.900M
YoY Change	26.77%	5.41%
Cash From Operating Activities	$10.42M	$7.381M
YoY Change	41.15%	-51.38%
INVESTING ACTIVITIES
Capital Expenditures	$5.608M	$12.56M
YoY Change	-55.35%	344.57%
Acquisitions
YoY Change
Other Investing Activities	-$1.079M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	-$3.445M	-$38.00M
YoY Change	-90.93%	425.81%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$10.83M	-$7.656M
YoY Change	41.46%	-251.07%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$15.42M	$14.29M
YoY Change	7.92%	145.68%
NET CHANGE
Cash From Operating Activities	$10.42M	$7.381M
Cash From Investing Activities	-$3.445M	-$38.00M
Cash From Financing Activities	$15.42M	$14.29M
Net Change In Cash	$22.40M	-$16.32M
YoY Change	-237.21%	-218.53%
FREE CASH FLOW
Cash From Operating Activities	$10.42M	$7.381M
Capital Expenditures	$5.608M	$12.56M
Free Cash Flow	$4.810M	-$5.178M
YoY Change	-192.89%	-141.91%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	670732000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	74247000	USD
CY2013Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	64635000	USD
CY2012Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8333000	USD
CY2013Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6410000	USD
CY2013Q1	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	8996000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2349000	USD
CY2013Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1207000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	572000	USD
CY2013Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	19748000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19549000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	98992000	USD
CY2013Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	108672000	USD
CY2013Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	595000	USD
CY2013Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	151000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	203000	USD
CY2013Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	694334000	USD
CY2012Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4863000	USD
CY2012Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1146000	USD
CY2013Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1089000	USD
CY2013Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2012Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	800000	shares
CY2013Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	26320000	USD
CY2012Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2013Q1	us-gaap	Assets Assets	726245000	USD
CY2012Q4	us-gaap	Assets Assets	756312000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	485793000	USD
CY2013Q1	us-gaap	Assets Current AssetsCurrent	527331000	USD
CY2013Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	48655000	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	49737000	USD
CY2012Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	28485000	USD
CY2013Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	37975000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	37975000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	28485000	USD
CY2012Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	21252000	USD
CY2013Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	10680000	USD
CY2012Q4	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	21252000	USD
CY2013Q1	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	10680000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	306386000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	328745000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	240675000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	224361000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16314000	USD
CY2013Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	22359000	USD
CY2012Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16314000	USD
CY2013Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2013Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2013Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	81725000	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	80611000	shares
CY2013Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	81725000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	80611000	shares
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2013Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2012Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21131000	USD
CY2013Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-42035000	USD
CY2013Q1	us-gaap	Cost Of Revenue CostOfRevenue	40731000	USD
CY2012Q1	us-gaap	Cost Of Revenue CostOfRevenue	34319000	USD
CY2013Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate DebtInstrumentBasisSpreadOnVariableRate	0.0175
CY2012Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4726000	USD
CY2013Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	931000	USD
CY2013Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	59472000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	61975000	USD
CY2013Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	28417000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	21609000	USD
CY2012Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2753000	USD
CY2013Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3855000	USD
CY2013Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2012Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.26
CY2012Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2013Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2012Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	9000	USD
CY2013Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-37000	USD
CY2012Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.228
CY2013Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.075
CY2013Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	31246000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	39621000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	8043000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	7739000	USD
CY2012Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	8043000	USD
CY2013Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	7739000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1971000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2610000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2610000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2610000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2616000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53325000	USD
CY2013Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	25429000	USD
CY2012Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23511000	USD
CY2013Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30348000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	99236000	USD
CY2013Q1	us-gaap	Goodwill Goodwill	58543000	USD
CY2013Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	40693000	USD
CY2012Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2013Q1	us-gaap	Gross Profit GrossProfit	112849000	USD
CY2012Q1	us-gaap	Gross Profit GrossProfit	100760000	USD
CY2013Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39063000	USD
CY2012Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27194000	USD
CY2013Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2920000	USD
CY2012Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6210000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1611000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3641000	USD
CY2013Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9240000	USD
CY2012Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2398000	USD
CY2013Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-7941000	USD
CY2012Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-9191000	USD
CY2013Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1476000	USD
CY2012Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	1809000	USD
CY2013Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	320000	USD
CY2012Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4030000	USD
CY2013Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	586000	USD
CY2012Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1530000	USD
CY2012Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-3000	USD
CY2013Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1053000	USD
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45777000	USD
CY2013Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25429000	USD
CY2013Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4865000	USD
CY2012Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3604000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	15122000	USD
CY2013Q1	us-gaap	Inventory Net InventoryNet	15442000	USD
CY2012Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	7629000	USD
CY2013Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	7381000	USD
CY2013Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	3196000	USD
CY2012Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3889000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	174995000	USD
CY2013Q1	us-gaap	Liabilities Liabilities	165127000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	756312000	USD
CY2013Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	726245000	USD
CY2013Q1	us-gaap	Liabilities Current LiabilitiesCurrent	143855000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	155771000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14291000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15423000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14291000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37995000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3445000	USD
CY2013Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10418000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7381000	USD
CY2012Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7381000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	20984000	USD
CY2013Q1	us-gaap	Net Income Loss NetIncomeLoss	-41983000	USD
CY2013Q1	us-gaap	Noncurrent Assets NoncurrentAssets	72672000	USD
CY2012Q4	us-gaap	Noncurrent Assets NoncurrentAssets	79191000	USD
CY2013Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-988000	USD
CY2012Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-812000	USD
CY2013Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2013Q1	us-gaap	Operating Expenses OperatingExpenses	150924000	USD
CY2012Q1	us-gaap	Operating Expenses OperatingExpenses	72754000	USD
CY2012Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	28006000	USD
CY2013Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-38075000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	23815000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2245000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	4779000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5139000	USD
CY2013Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	6421000	USD
CY2013Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4839000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3740000	USD
CY2013Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3173000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3454000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-12000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	3000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	159000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-55000	USD
CY2012Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	147000	USD
CY2013Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-52000	USD
CY2013Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	21272000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	19224000	USD
CY2012Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-52000	USD
CY2013Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	10000	USD
CY2012Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2013Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-26000	USD
CY2012Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2524000	USD
CY2013Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2438000	USD
CY2013Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3141000	USD
CY2012Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	1408000	USD
CY2012Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	28190000	USD
CY2013Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	3282000	USD
CY2012Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12559000	USD
CY2013Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5608000	USD
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2013Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2013Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2013Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35233000	USD
CY2013Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	35989000	USD
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10180000	USD
CY2013Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13268000	USD
CY2013Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5000	USD
CY2012Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
CY2012Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	2751000	USD
CY2013Q1	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	4366000	USD
CY2013Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	72672000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79191000	USD
CY2013Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11282000	USD
CY2012Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10526000	USD
CY2013Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	508000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1575000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-89626000	USD
CY2013Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-133375000	USD
CY2013Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	4890000	USD
CY2012Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	5253000	USD
CY2013Q1	us-gaap	Sales Revenue Net SalesRevenueNet	153580000	USD
CY2012Q1	us-gaap	Sales Revenue Net SalesRevenueNet	135079000	USD
CY2012Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	38717000	USD
CY2013Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	42281000	USD
CY2012Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4863000	USD
CY2013Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6410000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.537
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.467
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.002
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.002
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2158000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	14.85
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	65000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	11.17
CY2012Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	9.08
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	46054000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2551000	shares
CY2011Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3276000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	15.46
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	45826000	USD
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2535000	shares
CY2013Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	15.43
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y2M
CY2012Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y2M
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	40263000	USD
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y11M19D
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y0M15D
CY2013Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y0M11D
CY2012Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3151000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4050000	USD
CY2011Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3177000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	4129000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	4129000	USD
CY2012Q4	us-gaap	Standard Product Warranty Accrual Current StandardProductWarrantyAccrualCurrent	4050000	USD
CY2012Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	914000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	1184000	USD
CY2013Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	1263000	USD
CY2012Q1	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	888000	USD
CY2013Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	660000	shares
CY2013Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	100000	shares
CY2013Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	2400000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	581317000	USD
CY2013Q1	us-gaap	Stockholders Equity StockholdersEquity	561118000	USD
CY2013Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22100000	USD
CY2013Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	1400000	USD
CY2013Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of estimates</font></div><div style="line-height:120%;text-indent:16px;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S.”) requires our management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, we evaluate our estimates, including those related to the fair values of financial instruments, long-lived assets and goodwill, useful lives of intangible assets and property and equipment, stock-based compensation, income taxes, and contingent liabilities, among others. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</font></div></div>
CY2013Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2012Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2621000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81856000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81248000	shares
CY2012Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79235000	shares
CY2013Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	81248000	shares
CY2013Q1	algn	Accrued Accounts Payable AccruedAccountsPayable	2230000	USD
CY2012Q4	algn	Accrued Accounts Payable AccruedAccountsPayable	2866000	USD
CY2012Q4	algn	Accrued Distributor Expenses Current AccruedDistributorExpensesCurrent	1800000	USD
CY2013Q1	algn	Accrued Distributor Expenses Current AccruedDistributorExpensesCurrent	2300000	USD
CY2012Q4	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	4088000	USD
CY2013Q1	algn	Accrued Sales And Marketing Current AccruedSalesAndMarketingCurrent	3695000	USD
CY2012Q4	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	2484000	USD
CY2013Q1	algn	Allowance For Doubtful Accounts Receivable And Sales Returns Current AllowanceForDoubtfulAccountsReceivableAndSalesReturnsCurrent	1247000	USD
CY2013Q1	algn	Finite Lived Intangible Assets Accumulated Amortization Period Increase Decrease FiniteLivedIntangibleAssetsAccumulatedAmortizationPeriodIncreaseDecrease	8638000	USD
CY2013Q1	algn	Finite Lived Intangible Assets Accumulated Impairment Loss FiniteLivedIntangibleAssetsAccumulatedImpairmentLoss	19258000	USD
CY2013Q1	algn	Future Amortization Expense Thereafter FutureAmortizationExpenseThereafter	13012000	USD
CY2013Q1	algn	Marketable Securities Weighted Average Remaining Maturity MarketableSecuritiesWeightedAverageRemainingMaturity	P6M
CY2012	algn	Marketable Securities Weighted Average Remaining Maturity MarketableSecuritiesWeightedAverageRemainingMaturity	P10M
CY2012Q4	algn	Merger Consideration Payable MergerConsiderationPayable	1575000	USD
CY2013Q1	algn	Merger Consideration Payable MergerConsiderationPayable	508000	USD
CY2013Q1	algn	Operating Leases Future Minimum Payments Due Remainder Of Period OperatingLeasesFutureMinimumPaymentsDueRemainderOfPeriod	5231000	USD
CY2013Q1	algn	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts	-1196000	USD
CY2012Q1	algn	Provision And Recovery For Doubtful Accounts ProvisionAndRecoveryForDoubtfulAccounts	-119000	USD
CY2013Q1	algn	Share Repurchases Price Paid Per Share ShareRepurchasesPricePaidPerShare	32.47
CY2013Q1	algn	Standard Product Warranty Time Period StandardProductWarrantyTimePeriod	P1Y
CY2013Q1	dei	Amendment Flag AmendmentFlag	false
CY2013Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2013Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2013Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
CY2013Q1	dei	Document Period End Date DocumentPeriodEndDate	2013-03-31
CY2013Q1	dei	Document Type DocumentType	10-Q
CY2013Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001097149
CY2013Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	81557143	shares
CY2013Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2013Q1	dei	Entity Registrant Name EntityRegistrantName	ALIGN TECHNOLOGY INC
CY2013Q1	dei	Trading Symbol TradingSymbol	ALGN

Files In Submission

Name	View Source	Status
0001097149-13-000016-index-headers.html	Edgar Link	pending
0001097149-13-000016-index.html	Edgar Link	pending
0001097149-13-000016.txt	Edgar Link	pending
0001097149-13-000016-xbrl.zip	Edgar Link	pending
algn-2013031xex101.htm	Edgar Link	pending
algn-20130331.xml	Edgar Link	completed
algn-20130331.xsd	Edgar Link	pending
algn-20130331_cal.xml	Edgar Link	unprocessable
algn-20130331_def.xml	Edgar Link	unprocessable
algn-20130331_lab.xml	Edgar Link	unprocessable
algn-20130331_pre.xml	Edgar Link	unprocessable
algn-2013331xex311.htm	Edgar Link	pending
algn-2013331xex312.htm	Edgar Link	pending
algn-2013331xex321.htm	Edgar Link	pending
algn-2013331xq1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
q113utilizationgraph.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALGN
ALIGN TECHNOLOGY INC Stock $algn

2013 Q1 Form 10-Q Financial Statement

#000109714913000016 Filed on May 03, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN ALIGN TECHNOLOGY INC Stock $algn

2013 Q1 Form 10-Q Financial Statement

#000109714913000016 Filed on May 03, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALGN
ALIGN TECHNOLOGY INC Stock $algn